Pitofsky Jason bought REGN
February 9, 2026 · Form 4 insider transaction
Pitofsky Jason bought 1,000 shares of Regeneron Pharmaceuticals, Inc. at $492.00 per share, a transaction worth $492.0K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,000
Price
$492.00
Total value
$492.0K
InsiderPitofsky Jason
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateFebruary 9, 2026
Filing dateFebruary 11, 2026
Shares owned after6,308
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on November 10, 2025.